Author:
Kim Hyojin,Eun Shin,Jeong Woo-Jin,Ahn Soon-Hyun,Bae Yun Jung,Lee Joong Seob,Kim Heejin
Abstract
AbstractCarcinoma ex pleomorphic adenoma (CXPA) is a rare malignancy that transforms from PA. Early detection of the carcinoma by biopsy is difficult due to similar histopathology of the malignant and benign components. To address this, we investigated and compared the characteristic miRNA expression patterns across samples of the PA, carcinomatous portions (CA) of CXPA, as well as conventional PA. We selected 13 CXPA and 16 conventional PA FFPE samples, separated the PA and CA portions of CXPA samples and conducted miRNA profiling for each group. Among 13 transcripts that were differentially expressed between PA and CA of CXPA, eight miRNAs were up-regulated and five down-regulated in CA. Bioinformatic analysis revealed that the up-regulated miRNAs were related to cancer progression and down-regulated ones to tumor suppression. Additionally, seven miRNAs were significantly up-regulated in PA of CXPA compared to conventional PA, although they are histopathologically similar. Almost all of these transcripts interacted with TP53, a well-known tumor suppressor. In conclusion, we identified differentially expressed miRNAs in PA and CA of CXPA, which were closely associated with TP53 and various cancer-related pathways. We also identified differentially expressed miRNAs in the PA of CXPA and conventional PA which may serve as potential biomarkers.
Publisher
Springer Science and Business Media LLC
Reference40 articles.
1. Lüers, J. C., Wittekindt, C., Streppel, M. & Guntinas-Lichius, O. Carcinoma ex pleomorphic adenoma of the parotid gland. Study and implications for diagnostics and therapy. Acta Oncol. 48, 132–136 (2009).
2. Chen, M. M., Roman, S. A., Sosa, J. A. & Judson, B. L. Predictors of survival in carcinoma ex pleomorphic adenoma. Head Neck 36, 1324–1328 (2014).
3. Gupta, A., Koochakzadeh, S., Neskey, D. M., Nguyen, S. A. & Lentsch, E. J. Carcinoma ex pleomorphic adenoma: A review of incidence, demographics, risk factors, and survival. Am. J. Otolaryngol. 40, 102279 (2019).
4. Lewis, J. E., Olsen, K. D. & Sebo, T. J. Carcinoma ex pleomorphic adenoma: Pathologic analysis of 73 cases. Hum. Pathol. 32, 596–604 (2001).
5. Antony, J., Gopalan, V., Smith, R. A. & Lam, A. K. Carcinoma ex pleomorphic adenoma: A comprehensive review of clinical, pathological and molecular data. Head Neck Pathol. 6, 1–9 (2012).
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献